Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |